SCHEMBL14715753

SCHEMBL14715753

CCONc1ccccc1OCC

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.54
▸ ALDH1A1 P00352 6/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ MAPK10 P53779 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ LMNA P02545 2/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ MCL1 Q07820 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ EGFR P00533 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11300182 0.84 GAA (0.54) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL11521594 0.81 MAPK10 (0.62) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL1639715 0.81 GAA (0.59) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL947416 0.79 GAA (0.58) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL27688905 0.78 GAA (0.56) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL31130141 0.78 GAA (0.56) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL27685405 0.78 GAA (0.61) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL147183 0.78 GAA (0.56) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL20508889 0.78 GAA (0.56) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL1994661 0.78 GAA (0.56) GAAALDH1A1KMT2ACYP2C19MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3044208-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2021-12-22 — — EP disclosed
US-10793555-B2 Oxime ester photoinitiators BASF SE (DE) 2020-10-06 — — US disclosed
US-20180208583-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-07-26 — — US disclosed
EP-3044208-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2016-07-20 — — EP disclosed
WO-2015036910-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2015-03-19 — — WO disclosed
EP-1957457-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2013-02-27 — — EP disclosed
CN-1678284-A Dyeing method for porous material CIBA SC HOLDING AG (CH) 2005-10-05 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10793555-B2 Oxime ester photoinitiators NR2E3, OXER1, CBR3 GAA 4812/4885ALDH1A1 929/4885KMT2A 1467/4885
US-20180208583-A1 OXIME ESTER PHOTOINITIATORS NR2E3, OXER1, CBR3 GAA 4812/4885ALDH1A1 929/4885KMT2A 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback